Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-205-3 | CAS number: 10595-60-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- Not reported
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Study conducted in accordance with generally accepted scientific principles, although with incomplete reporting or methodological deficiencies. This reference does not provide a full report with regard to the methods used in this study. Most basic key information is reported.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Standard FHSA procedures
- Deviations:
- not specified
- Principles of method if other than guideline:
- Groups of fasted rats were administered a single oral dose of the undiluted test material and observed for 14 days.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- N,N'-bis(1,3-dimethylbutylidene)-2,2'-iminobis(ethylamine)
- EC Number:
- 234-205-3
- EC Name:
- N,N'-bis(1,3-dimethylbutylidene)-2,2'-iminobis(ethylamine)
- Cas Number:
- 10595-60-5
- Molecular formula:
- C16H33N3
- IUPAC Name:
- N-(1,3-dimethylbutylidene)-N'-{2-[(1,3-dimethylbutylidene)amino]ethyl}ethane-1,2-diamine
- Test material form:
- other: watery liquid
- Details on test material:
- - Physical details: light amber, watery liquid with a highly noticeable odour
- Storage conditions: ambient room temperature
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 204 to 307 g
- Fasting period before study: Yes, 16 to 20 hours
- Diet (e.g. ad libitum): ad libitum Wayne diet
- Water (e.g. ad libitum): ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 1.0, 2.0 and 4.0 mL/kg
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs and bodyweight - Statistics:
- LD50 is calculated by probit transformation based on 14 days’ observation.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 1.88 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.56 - 2.27
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 2.13 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.52 - 3.01
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1.64 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- 1.17 - 2.31
- Mortality:
- Mortality data is summarised in Table 1.
In the 4.0 mL/kg dose group, all animals died. Of the male animals, 3 died within 4 hours of dosing with the remaining 2 dying 1 day after dosing. All female animals died on the day of dosing, 4 within 1 hour.
In the 2.0 mL/kg dose group, 2 male and 4 female animals died. Of the males, 1 died 1 day after dosing and the other died 2 days after dosing. Of the 4 female animals, a single death occurred on days 3, 4, 7 and 9 after dosing. - Clinical signs:
- other: Clinical signs are summarised in Table 1. Animals in the 4.0 mL/kg dose group exhibited languidness and ataxia 5 minutes after dosing. Other signs included depressed respiration and an impaired righting reflex. Animals in the 2.0 mL/kg dose group exhibi
- Gross pathology:
- Animals dosed at 4.0 mL/kg exhibited congestion of the lungs, liver, spleen, stomach, and small intestines. Congestion of the left kidney was seen in 1 animal. Five of the 10 animals exhibited bloody urine in the bladder. Diffuse white opacity inside the right eye was seen in 2 animals. Dilation of the right renal pelvis was seen in 2 of the 10.
Animals dosed at 2.0 mL/kg that died exhibited congested lungs, dark red liver and a stomach that was distended and hemorrhagic. Opacities inside one or both eyes were seen in 3 animals, and dark red eyes were seen in 2.
Gross pathology seen in the animals that survived to the end of the observation period were the stomach, liver, and spleen adhered to left abdominal wall, thickened stomach walls and partial atelectasis of lungs. A light-coloured, mottled liver was seen in 1 animal.
In the animals that were dosed at 1.0 mL/kg, 3 of the 10 exhibited the stomach adhered to the liver, spleen or diaphragm. One animals showed dilation of the right renal pelvis, however hydronephrosis is a common finding in this strain of rat.
Any other information on results incl. tables
Table 1 Summary of Mortality and Clinical Signs
Dosage (mL/kg) |
Sex |
No. of Deaths / No. Dosed |
Days to Death |
Weight Change in 14 Days (g) |
Clinical Signs |
||||
4.0 |
Male |
5/5 |
0, 0, 0, 1, 1 |
- |
Languidness and ataxia in 5/5 at 5 min. Death of 3/5 within 4 hours. Languidness, ataxia, depressed respiration, and impaired righting reflex in 3/3 at 3 hours. |
||||
Female |
5/5 |
0, 0, 0, 0, 0 |
- |
Languidness and ataxia in 5/5 at 5 min. Death of 4/5 within 1 hour. Languidness, ataxia, depressed respiration, and severely impaired righting reflex in 1/1 at 3 hours. |
|||||
2.0 |
Male |
2/5 |
1, 2 |
-76, +65, +66 |
Languidness, ataxia, injected corneal blood vessels, lacrimation, urine stains, squinting and miosis at 1 day. Hunched appearance, chromodacryorrhea, dark red eyes and thinness from 3 to 14 days. |
||||
Female |
4/5 |
3, 4, 7, 9 |
+36 |
Ataxia, languidness, urine stains, injected corneal blood vessels, hunched appearance, chromodacryorrhea, and miosis at 1 day. Pilo-erection, dark red eyes, bloody nose and rigid, erect tail (1/4) at 3 days. Languidness, thinness, dark red eyes, and pilo-erection from 4 to 9 days. |
|||||
1.0 |
Male |
0/5 |
- |
+58 to +87 (Mean +74.2) |
Nothing abnormal.
|
||||
Female |
0/5 |
- |
+22 to +52 (Mean +37.4) |
Congestion of iridial blood vessels in 2/5 at 3 hours.
|
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study, the LD50 in the Albino rat was determined to be 1.88 mL/kg, 95 % confidence limits 1.56 to 2.27 mL/kg.
- Executive summary:
The acute peroral toxicity of the test material to the Albino rat was investigated in accordance with standard FHSA procedures.
Groups of five male and five female fasted rats were dosed with the undiluted test material at 4.0, 2.0, and 1.0 mL/kg and observed for 14 days.
All animals dosed at 4.0 mL/kg died within one day of dosing; gross necropsy of these animals revealed congestion or haemorrhage in most of the pleural and abdominal viscera. Six of the animals dosed with 2.0 mL/kg died within 9 days of dosing.
All survivors exhibited signs of distress and bodyweight gain below normal for animals of this age.
Under the conditions of this study, the LD50 in the Albino rat was determined to be 1.88 mL/kg, 95 % confidence limits 1.56 to 2.27 mL/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.